Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPF and UVA Protection Assay of BAY987516
NCT02930798Completed
- Sponsor
- Bayer
- Start
- Oct 2016
- Primary completion
- Oct 2016
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
Open-label, single-arm trial of BAY 987516 in sunburn, sponsored by Bayer. Primary endpoint: Minimal Erythema Dose at 15 months. Started Oct 2016; status: completed.
02
Drugs
BAY 987516
03
Conditions
sunburn
Beyond the preview
Go deeper on NCT02930798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02930798.